Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Leukopenia in Chronic Kidney Disease Patients

Primary Causes of Leukopenia in CKD

  • Immunosuppressive medications in transplant recipients are a major cause of leukopenia, particularly myelosuppressive drugs like azathioprine and mycophenolate mofetil, according to the American Journal of Kidney Diseases 1
  • Antiviral medications (ganciclovir) and antibiotics (trimethoprim-sulfamethoxazole) commonly used in CKD patients can cause leukopenia, as reported by the American Journal of Kidney Diseases 1
  • Sirolimus has been associated with dose-dependent anemia and may potentially affect white blood cell production through similar mechanisms, as noted by the American Journal of Kidney Diseases 1
  • Cytomegalovirus (CMV) infection is a significant cause of leukopenia in CKD patients, especially in transplant recipients, according to the American Journal of Kidney Diseases 1
  • Parvovirus B19 infection can cause bone marrow suppression affecting multiple cell lines, as reported by the American Journal of Kidney Diseases 1

Evaluation of Leukopenia in CKD

  • Complete blood count with differential to determine which white cell lines are affected is recommended by Kidney International Supplements 2, 3
  • Evaluate for abnormalities in other cell lines (anemia, thrombocytopenia) which may suggest broader bone marrow dysfunction, as suggested by Kidney International Supplements 2
  • Review medication list for potential myelosuppressive agents, according to the American Journal of Kidney Diseases 1

Additional Testing and Management

  • Viral studies for CMV, parvovirus B19, and other potential viral causes are recommended by the American Journal of Kidney Diseases 1
  • Evaluation of inflammatory markers (C-reactive protein) to assess contribution of inflammation is suggested by Kidney International Supplements 4
  • Regular monitoring of complete blood count in CKD patients, particularly those on medications with known myelosuppressive effects, is recommended by Kidney International Supplements 2